Opko Health Inc
OPK
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.14B
Close$
$-0.75
146.8% downside
Current Fair Value
146.8% downsideOvervalued by 146.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.14 Billion |
|---|---|
| Enterprise Value | $1.23 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.3 |
| Beta | 1.5 |
| Outstanding Shares | 755,267,276 |
Return
| Return on Equity | -2.82% |
|---|---|
| Return on Assets | -1.82% |
| Return on Invested Capital | -3.38% |
Valuation & Multiples
| P/E Ratio | -16.05 |
|---|---|
| PEG | 17.02 |
| Price to Sales | - |
| Price to Book Ratio | 1.61 |
| Enterprise Value to Revenue | 2.1 |
| Enterprise Value to EBIT | -21.7 |
| Enterprise Value to Net Income | -37 |
| Total Debt to Enterprise | 0.32 |
| Debt to Equity | 0.33 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 30, 2026
EPS Estimate
$-0.08
Average shareholder expectationRevenue Estimate
$131.23 M
Average shareholder expectationNext Earnings Call
Expected Date
November 4, 2026
EPS Estimate
$-0.07
Average shareholder expectationRevenue Estimate
$136.62 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.3103▼ 8.96% |
|---|---|
| Total Calls | 195,621▲ 29.53% |
| Total Puts | 60,700▲ 0.50% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 27.28%▲ 0.78% |
|---|---|
| Total Invested | $308.83M▲ 34.72% |
| Investors Holding | 229▼ 9.00% |
ESG Score
No data
About Opko Health Inc
2,275 employees
CEO: Phillip Frost OPKO Health, Inc. operates as a healthcare enterprise with a dual focus on diagnostics and pharmaceuticals. Its operations span the United States, Ireland, Chile, Spain, Israel, Mexico, and other international markets. The company's Diag...